42
Participants
Start Date
March 5, 2025
Primary Completion Date
August 31, 2027
Study Completion Date
August 31, 2027
RXRG001
Circular ribonucleic acid encoding human aquaporin 1 encapsulated in a lipid nanoparticle
Placebo
Placebo (saline)
RECRUITING
Penn Medicine - Otorhinolaryngology - Head and Neck Surgery Perelman, Philadelphia
RECRUITING
John Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore
RECRUITING
University of Iowa Hospitals and Clinics, Iowa City
RiboX Therapeutics Ltd.
INDUSTRY